Skip to main content
S 1062 115th Congress Senate Health Computers and information technology Congressional oversight Department of Health and Human Services Drug safety, medical device, and laboratory regulation Food and Drug Administration (FDA) Government buildings, facilities, and property Government employee pay, benefits, personnel management Government information and archives Licensing and registrations Performance measurement Prescription drugs Public contracts and procurement Public participation and lobbying User charges and fees

FDA Reporting Transparency and Accountability Act

Introduced: May 4, 2017 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 4, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 4, 2017
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

FDA Reporting Transparency and Accountability Act

This bill expands reporting requirements related to the performance of the Food and Drug Administration (FDA), including to require additional information on timeliness and personnel and publication every 30 days of information regarding FDA guidance and meetings.

What's happening now May 4, 2017

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Related & companion bills 2
  • HR 2430 Related bill FDA Reauthorization Act of 2017
  • S 934 Related bill FDA Reauthorization Act of 2017
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Republican 1
R
Young, Todd
Indiana · May 4, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1062: FDA Reporting Transparency and Accountability Act. 115th Congress. Open America. https://openamerica.io/bill/115-S-1062/
MLA
"S. 1062: FDA Reporting Transparency and Accountability Act." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-S-1062/.
Bluebook (legal)
S. 1062, 115th Cong. (2026), https://openamerica.io/bill/115-S-1062/.
Markdown link
[S. 1062: FDA Reporting Transparency and Accountability Act](https://openamerica.io/bill/115-S-1062/)
Report a problem